According to the Tianyancha App, recently, Ali Health Technology (China) Co., Ltd. has undergone industrial and commercial changes. Zhu Shunyan resigned from the legal representative, chairman, and general manager positions, and Shen Difan was appointed as the legal representative, director, and manager. At the same time, several key personnel also underwent changes. The company was established in August 2015, with a registered capital of 0.8 billion RMB, and is wholly owned by Ali Health (Hong Kong) Technology Co., Ltd. In November last year, Ali Health (HK.00241) announced on the Hong Kong Stock Exchange that executive director Shen Difan had been appointed as the CEO of the company and one of the authorized representatives under the listing rules of the Hong Kong Stock Exchange.
沈涤凡任阿里健康科技法定代表人
Shen Difan serves as the legal representative of ali health technology.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.